Abstract
Purpose
Purposes are (1) to measure main radiation parameters and (2) to propose a method to estimate the absorbed doses of internal organs starting from DAP values. Measuring the exposition of internal organs by repeated irradiations on an anthropomorphic phantom with the same settings used in vivo, we could establish correlations between (1) DAP and the dose recorded by a dosimeter placed along the X-ray beam entrance pathway; (2) the dose recorded by the same dosimeter and the absorbed dose in internal organs.
Methods
Forty-four consecutive patients (16 males, 28 females) (mean age 35.4 months) treated at our institution with IAC (216 procedures: 196 via the ICA and 20 into branches of the ECA) were included in this prospective study. IAC was divided into 5 phases. Fluoroscopic time, DAP, and ESD were measured.
Results
The mean DAP was 595 ± 445 cGy cm2 and the mean fluoroscopic time was 540 ± 403 s. ESD was on average 9.59 mGy (range 0.8–165 mGy). The absorbed dose was lower than 12.1 mGy in the left retina (the more exposed organ) in 75% of single treatments and lower than 25 mGy in 95% of treatments. In the cases of 3 and 6 sessions, the left retina of 75% of patients absorbed respectively less than 36.3 and 72.7 mGy, whereas the left retina of 95% of patients received less than 75.2 and 150.4 mGy. Other organs were less exposed.
Conclusion
This paper describes a method of absorbed dose estimation providing ranges used clinically in a single practice and the basis for further prospective studies.
Similar content being viewed by others
Abbreviations
- IAC:
-
Intra-arterial chemotherapy
- ICA:
-
Internal carotid artery
- ECA:
-
External carotid artery
- DAP:
-
Dose area product
- ESD:
-
Entrance skin dose
- OA:
-
Ophthalmic artery
- SID:
-
Source-to-image receptor distance
- FOV:
-
Field of view
- TLD:
-
Thermoluminescence dosimeters
References
Wyse E, Handa JT, Friedman AD, Pearl MS (2016) A review of the literature for intra-arterial chemotherapy used to treat retinoblastoma. Pediatr Radiol 46:1223–1233
Vijayakrishnan R, Shields CL, Ramasubramanian A, Emrich J, Rosenwasser R, Shields JA (2010) Irradiation toxic effects during intra-arterial chemotherapy for retinoblastoma: should we be concerned? Arch Ophthalmol 128:1427–1431
Gobin YP, Rosenstein LM, Marr BP, Brodie SE, Abramson DH (2012) Radiation exposure during intra-arterial chemotherapy for retinoblastoma. Arch Ophthalmol 130:403–404 author reply 404-5
Kleinerman RA, Tucker MA, Tarone RE, Abramson DH, Seddon JM, Stovall M, Li FP, Fraumeni JF Jr (2005) Risk of new cancers after radiotherapy in long-term survivors of retinoblastoma: an extended follow-up. J Clin Oncol 23:2272–2279
Wong JR, Morton LM, Tucker MA, Abramson DH, Seddon JM, Sampson JN, Kleinerman RA (2014) Risk of subsequent malignant neoplasms in long-term hereditary retinoblastoma survivors after chemotherapy and radiotherapy. J Clin Oncol 32:3284–3290
Marees T, van Leeuwen FE, de Boer MR, Imhof SM, Ringens PJ, Moll AC (2009) Cancer mortality in long-term survivors of retinoblastoma. Eur J Cancer 45:3245–3253
Bracco S, Leonini S, De Francesco S et al (2013) Intra-arterial chemotherapy with melphalan for intraocular retinoblastoma. Br J Ophthalmol 97:1219–1221
Abruzzo TA, Geller JI, Kimbrough DA, Michaels S, Corrêa ZM, Cornell K, Augsburger JJ (2015) Adjunctive techniques for optimization of ocular hemodynamics in children undergoing ophthalmic artery infusion chemotherapy. J Neurointerv Surg 7:770–776
Bertelli E, Leonini S, Galimberti D, Moretti S, Tinturini R, Hadjistilianou T, de Francesco S, Romano DG, Vallone IM, Cioni S, Gennari P, Galluzzi P, Grazzini I, Rossi S, Bracco S (2016) Hemodynamic and anatomic variations require an adaptable approach during intra-arterial chemotherapy for intraocular retinoblastoma: alternative routes, strategies, and follow-up. AJNR Am J Neuroradiol 37:1289–1295
Klufas MA, Gobin YP, Marr B, Brodie SE, Dunkel IJ, Abramson DH (2012) Intra-arterial chemotherapy as a treatment for intraocular retinoblastoma: alternatives to direct ophthalmic artery catheterization. AJNR Am J Neuroradiol 33:1608–1614
Suzuki S, Yamane T, Mohri M, Kaneko A (2011) Selective ophthalmic arterial injection therapy for intraocular retinoblastoma: the long-term prognosis. Ophthalmology. 118:2081–2087
Rivera T (2012) Thermoluminescence in medical dosimetry. Applied Radiation and Isotopes. XII International Symposium on solid state dosimetry 71:30–34
European Council Directive 2013/59/Euratom on basic safety standards for protection against the dangers arising from exposure to ionising radiation and repealing Directives 89/618/Euratom, 90/641/Euratom, 96/29/Euratom, 97/43/Euratom and 2003/122/Euratom. OJ of the EU. (2014) L13; 57:1–73
Boddu SR, Abramson DH, Marr BP, Francis JH, Gobin YP (2017) Selective ophthalmic artery chemosurgery (SOAC) for retinoblastoma: fluoroscopic time and radiation dose parameters. A baseline study. J Neurointerv Surg 9:1107–1112
Bracco S, Venturi C, Leonini S, Romano DG, Cioni S, Vallone IM, Gennari P, Hadjistilianou T, de Francesco S, Bertelli E (2016) Transorbital anastomotic pathways between the external and internal carotid systems in children affected by intraocular retinoblastoma. Surg Radiol Anat 38:79–87
Bertelli E, Regoli M, Bracco S (2017) An update on the variations of the orbital blood supply and hemodynamic. Surg Radiol Anat 39:485–496
Bracco S, Bertelli E (2016) Reply. AJNR Am J Neuroradiol 37:E73
Cooke DL, Stout CE, Kim WT, Hetts SW, Higashida RT, Halbach VV, Dowd CF, Gould RG (2014) Radiation dose reduction in intra-arterial chemotherapy infusion for intraocular retinoblastoma. J Neurointerv Surg 6:785–789
Habib LA, Francis JH, Fabius AW et al (2018) Second primary malignancies in retinoblastoma patients treated with intra-arterial chemotherapy: the first 10 years. Br J Ophthalmol 102:272–275
National Council on Radiation Protection and Measurement (2009) Risks to the thyroid from ionizing radiation. NCRP Report No.159
Authors on behalf of ICRP, Stewart FA, Akleyev AV, Hauer-Jensen M et al (2012) ICRP publication 118: ICRP statement on tissue reactions and early and late effects of radiation in normal tissues and organs—threshold doses for tissue reactions in a radiation protection context. Ann ICRP 41:1–322
Funding
No funding was received for this study.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Guasti, A., Leonini, S., Bertelli, E. et al. Intra-arterial chemotherapy for retinoblastoma: the dosimetric impact. Neuroradiology 61, 1083–1091 (2019). https://doi.org/10.1007/s00234-019-02260-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00234-019-02260-7